29:
168:
and albumin. Polyethylene glycol (PEG) in a LISS solution removes water from the system and thus concentrates the antibodies present. PEG can cause non-specific aggregation of cells, thus eliminating the necessity for centrifugation after 37 °C (99 °F) incubation. PEG is not appropriate for
160:
around the suspended red blood cells, thus dispersing the repulsive negative charges and enhancing agglutination. Low ionic strength saline (LISS) is a potentiator that acts by not only reducing the
193:
out of an equal dose of an opioid medication. The potentiation can take place at any part of the liberation, absorption, distribution, metabolism and elimination of the drug.
173:. False-positive results may occur more frequently with the use of polyethylene glycol due to its strong agglutination capabilities.
242:
181:
In clinical pharmacology, a potentiator is a drug, herb, or chemical that intensifies the effects of a given drug. For example,
164:, but also by increasing the amount of antibody taken up by the red blood cell during sensitization. LISS is a solution of
93:
65:
220:
112:
72:
145:
to detect the presence of antibodies or antigens in a patient's blood sample. Examples of potentiators include
50:
79:
46:
247:
61:
142:
39:
17:
8:
150:
86:
216:
186:
170:
169:
use in samples from patients with increased plasma protein, such as patients with
161:
157:
236:
146:
182:
190:
138:
28:
16:"potentiation" redirects here. For the concept in neuroscience, see
137:. Potentiators are used in the clinical laboratory for performing
165:
134:
130:
153:). Potentiators are also known as enhancement reagents.
210:
53:. Unsourced material may be challenged and removed.
234:
213:Modern Blood Banking & Transfusion Practices
156:Albumin acts as a potentiator by reducing the
149:, LISS (low ionic-strength saline) and PEG (
113:Learn how and when to remove this message
141:procedures that require enhancement of
235:
189:is used to get more pain relief and
51:adding citations to reliable sources
22:
13:
133:that enhances sensitization of an
14:
259:
27:
176:
38:needs additional citations for
243:Reagents for organic chemistry
203:
1:
211:Harmening, Denise M. (2005).
196:
7:
10:
264:
15:
215:. F. A. Davis Company.
18:long-term potentiation
125:In clinical terms, a
47:improve this article
151:polyethylene glycol
248:Chemical reactions
123:
122:
115:
97:
255:
227:
226:
207:
187:dextromethorphan
171:multiple myeloma
118:
111:
107:
104:
98:
96:
55:
31:
23:
263:
262:
258:
257:
256:
254:
253:
252:
233:
232:
231:
230:
223:
208:
204:
199:
179:
119:
108:
102:
99:
56:
54:
44:
32:
21:
12:
11:
5:
261:
251:
250:
245:
229:
228:
221:
201:
200:
198:
195:
178:
175:
162:zeta potential
158:zeta potential
121:
120:
35:
33:
26:
9:
6:
4:
3:
2:
260:
249:
246:
244:
241:
240:
238:
224:
222:0-8036-1248-6
218:
214:
206:
202:
194:
192:
188:
184:
174:
172:
167:
163:
159:
154:
152:
148:
144:
143:agglutination
140:
139:blood banking
136:
132:
128:
117:
114:
106:
95:
92:
88:
85:
81:
78:
74:
71:
67:
64: –
63:
62:"Potentiator"
59:
58:Find sources:
52:
48:
42:
41:
36:This article
34:
30:
25:
24:
19:
212:
205:
180:
177:Pharmacology
155:
126:
124:
109:
100:
90:
83:
76:
69:
57:
45:Please help
40:verification
37:
183:hydroxyzine
127:potentiator
237:Categories
197:References
191:anxiolysis
103:April 2009
73:newspapers
166:glycine
147:albumin
135:antigen
131:reagent
87:scholar
219:
89:
82:
75:
68:
60:
129:is a
94:JSTOR
80:books
217:ISBN
66:news
185:or
49:by
239::
225:.
209:*
116:)
110:(
105:)
101:(
91:·
84:·
77:·
70:·
43:.
20:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
